Plasma miRNA expression levels in women with preeclampsia and chronic arterial hypertension in the first trimester of pregnancy

1. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. 2024. [Ministry of Health of the Russian Federation. Clinical guidelines. Preeclampsia. Eclampsia. Edema, proteinuria, and hypertensive disorders during pregnancy, childbirth, and the postpartum period. 2024. (in Russian)].
2. Kametas N.A., Nzelu D., Nicolaides K.H. Chronic hypertension and superimposed preeclampsia: screening and diagnosis. Am. J. Obstet. Gynecol. 2022; 226(2S): S1182-95. https://dx.doi.org/10.1016/j.ajog.2020.11.029
3. DeSisto C.L., Robbins C.L., Ritchey M.D., Ewing A.C., Ko J.Y., Kuklina E.V. Hypertension at delivery hospitalization – United States, 2016–2017. Pregnancy Hypertens. 2021; 26: 65-8. https://dx.doi.org/10.1016/j.preghy.2021.09.002
4. Greenberg V.R., Silasi M., Lundsberg L.S., Culhane J.F., Reddy U.M., Partridge C. et al. Perinatal outcomes in women with elevated blood pressure and stage 1 hypertension. Am. J. Obstet. Gynecol. 2021; 224(5): 521.e1-11. https://dx.doi.org/10.1016/j.ajog.2020.10.049
5. Rezk M., Gamal A., Emara M. Maternal and fetal outcome in de novo preeclampsia in comparison to superimposed preeclampsia: a two-year observational study. Hypertens. Pregnancy. 2015; 34(2): 137-44. https://dx.doi.org/10.3109/10641955.2014.982329
6. Leimena C., Qiu H. Non-coding RNA in the pathogenesis, progression and treatment of hypertension. Int. J. Mol. Sci. 2018; 19(4): 927. https://dx.doi.org/10.3390/ijms19040927
7. Lopes A.C.S., Macedo A.A., Mendes F.S., Costa I.M., Dusse L.M.S., Alpoim P.N. Changes in microRNA expression associated with preeclampsia: a systematic review. Braz. J. Med. Biol. Res. 2025; 58: e13988. https://dx.doi.org/10.1590/1414-431X2025e13988
8. Никитина Н.А., Сидорова И.С., Райгородская М.П., Морозова Е.А., Тимофеев С.А., Агеев М.Б., Амирасланова Н.И. Эпигенетические механизмы развития преэклампсии: роль плазменных микроРНК. Архив акушерства и гинекологии им. В.Ф. Снегирёва. 2024; 11(2): 179-92. [Nikitina N.А., Sidorova I.S., Raygorodskaya M.Р., Morozova E.А., Timofeev S.А., Ageev M.В., Amiraslanova N.I. Epigenetic mechanisms of preeclampsia: Role of plasma microRNAs. V.F. Snegirev Archives of Obstetrics and Gynecology. 2024; 11(2): 179-92 (in Russian)]. https://dx.doi.org/10.17816/aog623622
9. Семенов Ю.А., Казачков Е.Л., Веряскина Ю.А., Чижовская А.В. Профиль экспрессии микроРНК в плазме крови беременных женщин с высоким и низким риском спонтанных преждевременных родов и перинатальных потерь. Южно-Уральский медицинский журнал. 2021; 2: 18-23. [Semyonov Yu.A., Kazachkov E.L., Veryaskina Yu.A., Chizhovskaya A.V. MicroRNA expression profile in the blood plasma of pregnant women with high and low risk of spontaneous preterm birth and perinatal loss. South Ural Medical Journal. 2021; 2: 18-23 (in Russian)].
10. Борис Д.А., Шмаков Р.Г. Преэклампсия: современные концепции патогенеза. Акушерство и гинекология. 2022; 12: 12-7. [Boris D.A., Shmakov R.G. Preeclampsia: modern concepts of pathogenesis. Obstetrics and Gynecology. 2022; (12): 12-7 (in Russian)]. https://dx.doi.org/10.18565/aig.2022.213
11. Hayder H., O'Brien J., Nadeem U., Peng C. MicroRNAs: crucial regulators of placental development. Reproduction. 2018; 155(6): R259-71. https://dx.doi.org/10.1530/REP-17-0603
12. Luizon M.R., Conceição I.M.C.A., Viana-Mattioli S., Caldeira-Dias M., Cavalli R.C., Sandrim V.C. Circulating MicroRNAs in the second trimester from pregnant women who subsequently developed preeclampsia: potential candidates as predictive biomarkers and pathway analysis for target genes of miR-204-5p. Front. Physiol. 2021; 12: 678184. https://dx.doi.org/10.3389/fphys.2021.678184
13. Celic T., Metzinger-Le Meuth V., Six I., Massy ZA., Metzinger L. The mir-221/222 cluster is a key player in vascular biology via the fine-tuning of endothelial cell physiology. Curr. Vasc. Pharmacol. 2017; 15(1): 40-6. https://dx.doi.org/10.2174/1570161114666160914175149
14. Naderi-Meshkin H., Setyaningsih W.A.W. Endothelial cell dysfunction: onset, progression, and consequences. Front. Biosci. (Landmark Ed). 2024; 29(6): 223. https://dx.doi.org/10.31083/j.fbl2906223
15. Alexandru N., Constantin A., Nemecz M., Comariţa IK., Vîlcu A., Procopciuc A. et al. Hypertension associated with hyperlipidemia induced different microRNA expression profiles in plasma, platelets, and platelet-derived microvesicles; effects of endothelial progenitor cell therapy. Front. Med. (Lausanne). 2019; 6: 280. https://dx.doi.org/10.3389/fmed.2019.00280
16. Yang Y., Li H., Ma Y., Zhu X., Zhang S., Li J. MiR-221-3p is down-regulated in preeclampsia and affects trophoblast growth, invasion and migration partly via targeting thrombospondin 2. Biomed. Pharmacother. 2019; 109: 127-34. https://dx.doi.org/10.1016/j.biopha.2018.10.009
17. Щербаков В.И., Поздняков И.М., Ширинская А.В. Уровень фактора-1α, индуцируемого гипоксией, и ассоциированных с ним молекул при преэклампсии. Российский вестник акушера-гинеколога. 2025; 25(1): 5-10. [Shcherbakov V.I., Pozdnyakov I.M., Shirinskaya A.V. Level of hypoxia-inducible factor-1α and associated molecules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025; 25(1): 5-10 (in Russian)]. https://dx.doi.org/10.17116/rosakush2025250115
18. Jaszczuk I., Koczkodaj D., Kondracka A., Kwaśniewska A., Winkler I., Filip A. The role of miRNA-210 in pre-eclampsia development. Ann. Med. 2022; 54(1): 1350-6. https://dx.doi.org/10.1080/07853890.2022.2071459
19. Youssef H.M.G., Marei E.S. Association of MicroRNA-210 and MicroRNA-155 with severity of preeclampsia. Pregnancy Hypertens. 2019; 17: 49-53. https://doi.org/10.1016/j.preghy.2019.05.010
20. Lumbers E.R., Delforce S.J., Arthurs A.L., Pringle K.G. Causes and consequences of the dysregulated maternal renin-angiotensin system in preeclampsia. Front. Endocrinol. (Lausanne). 2019; 10: 563. https://dx.doi.org/10.3389/fendo.2019.00563
21. Takeda Y., Demura M., Yoneda T., Takeda Y. Epigenetic regulation of the renin-angiotensin-aldosterone system in hypertension. Int. J. Mol. Sci. 2024; 25(15): 8099. https://doi.org/10.3390/ijms25158099
22. Артемьева К.А., Низяева Н.В., Баев О.Р., Романов А.Ю., Хлестова Г.В., Болтовская М.Н., Щеголев А.И., Кактурский Л.В. Регуляция ренин-ангиотензин-альдостероновой системы плаценты при ранней и поздней преэклампсии. Доклады Российской академии наук. Науки о жизни. 2022; 507(1): 475-82. [Artemieva K.A., Nizyaeva N.V., Baev O.R., Romanov A.Yu., Khlestova G.V., Boltovskaya M.N., Shchegolev A.I., Kakturskiy L.V. Regulation of the placental renin-angiotensin-aldosterone system in early and late onset preeclampsia. Reports of the Russian Academy of Sciences. Life sciences. 2022; 507(1): 475-82 (in Russian)]. https://dx.doi.org/10.31857/S2686738922060026
23. Lv B., He S., Li P. Jiang S., Li D., Lin J. et al. MicroRNA-181 in cardiovascular disease: emerging biomarkers and therapeutic targets. FASEB J. 2024; 38(9): e23635. https://doi.org/10.1096/fj.202400306R
24. Jackson K.L., Gueguen C., Lim K., Eikelis N., Stevenson E.R., Charchar F.J. et al. Neural suppression of miRNA-181a in the kidney elevates renin expression and exacerbates hypertension in Schlager mice. Hypertens. Res. 2020; 43(11): 1152-64. https://doi.org/10.1038/s41440-020-0453-x
25. Marques F.Z., Romaine S.P., Denniff M., Eales J., Dormer J., Garrelds I.M. et al. Signatures of miR-181a on the renal transcriptome and blood pressure. Mol. Med. 2015; 21(1): 739-48. https://dx.doi.org/10.2119/molmed.2015.00096
26. Hromadnikova I., Kotlabova K., Krofta L. Cardiovascular disease-associated MicroRNA dysregulation during the first trimester of gestation in women with chronic hypertension and normotensive women subsequently developing gestational hypertension or preeclampsia with or without fetal growth restriction. Biomedicines. 2022; 10(2): 256. https://dx.doi.org/10.3390/biomedicines10020256
27. Lin W., Teng S.W., Lin T.Y. Lovel R., Sung H.Y., Chang W.Y. et al. Combinatorial analysis of circulating biomarkers and maternal characteristics for preeclampsia prediction in the first and third trimesters in Asia. Diagnostics (Basel). 2022; 12(7): 1533. https://dx.doi.org/10.3390/diagnostics12071533
28. Никитина Н.А., Сидорова И.С., Райгородская М.П., Морозова Е.А., Тимофеев С.А., Агеев М.Б., Амирасланова Н.И. Роль микроРНК, ассоциированных с кардиоваскулярными заболеваниями и плацентарными нарушениями, в развитии преэклампсии. Вопросы гинекологии, акушерства и перинатологии. 2025; 24(2): 5-19. [Nikitina N.A., Sidorova I.S., Raigorodskaya M.P., Morozova E.A., Timofeev S.A., Ageev M.B., Amiraslanova N.I. Role of microRNAs associated with cardiovascular disease and placental abnormalities in the development of pre-eclampsia. Gynecology, Obstetrics and Perinatology. 2025; 24(2): 5-19 (in Russian)]. https://dx.doi.org/10.20953/1726-1678-2025-2-5-19
29. Wang Y., Zhang Y., Wang H., Wang J., Zhang Y., Wang Y. et al. Aberrantly up-regulated miR-20a in pre-eclampsic placenta compromised the proliferative and invasive behaviors of trophoblast cells by targeting forkhead box protein A1. Int. J. Biol. Sci. 2014; 10(9): 973-82. https://dx.doi.org/10.7150/ijbs.9088
30. Hu T.X., Wang G., Guo X.J., Sun Q.Q., He P., Gu H. et al. MiR 20a, -20b and -200c are involved in hydrogen sulfide stimulation of VEGF production in human placental trophoblasts. Placenta. 2016; 39: 101-10. https://dx.doi.org/10.1016/j.placenta.2016.01.019

Received 12.08.2025

Accepted 01.09.2025